FDA Inspection 883564 — Hisun Pharmaceutical Hangzhou Co., Ltd

Hisun Pharmaceutical Hangzhou Co., Ltd — FEI 3008481334

The FDA completed an inspection of Hisun Pharmaceutical Hangzhou Co., Ltd on April 11, 2014 in Hangzhou. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
April 11, 2014
Fiscal Year
2014
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Hangzhou (China)